![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SpineVision Receives FDA Clearance, CE Mark for Interbody Cage
SpineVision Receives FDA Clearance, CE Mark for Interbody Cage
![ClearanceStamp_Orange.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Orange.gif?t=1609798625&width=430)
September 18, 2018
French devicemaker SpineVision was granted 510(k) clearance from the FDA and the CE Mark for its titanium 3D laser-printed Hexanium interbody fusion cage for use in back surgery.
The transforaminal lumbar interbody fusion (TLIF) cage is used to fuse two vertebrae together and stop the movement of a painful segment in the spine.
The cage’s titanium surface promotes connection between bone and cage, and its honeycomb structure has large windows for maximum bone in-growth and on-growth between the cage’s endplates.
Upcoming Events
-
21Oct